BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15333076)

  • 1. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Epstein AE
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076
    [No Abstract]   [Full Text] [Related]  

  • 2. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
    Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 4. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between women and men with ICDs: myth or reality?
    Pelargonio G; Bisceglia C
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):979-81. PubMed ID: 19563354
    [No Abstract]   [Full Text] [Related]  

  • 6. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Bai R
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):678; author reply 678-9. PubMed ID: 15946376
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
    Köbe J; Eckardt L
    Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
    Botto GL; Luzi M; Russo G; Mariconti B
    G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiac resynchronization therapy].
    Karczmarewicz S
    Kardiol Pol; 2003 Jul; 59(7):83-5. PubMed ID: 14560359
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
    Cleland JG; Nasir M; Tageldien A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):90-101. PubMed ID: 17245403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
    [No Abstract]   [Full Text] [Related]  

  • 17. Device therapy in the management of congestive heart failure.
    Turer AT; Rao SV
    Cardiol Rev; 2005; 13(3):130-8. PubMed ID: 15831146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of right ventricular pacing in patients with dual-chamber ICDs.
    Olshansky B; Day J; McGuire M; Hahn S; Brown S; Lerew DR
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):237-43. PubMed ID: 16606390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.